Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Demographic profile, clinical features and treatment of patients diagnosed with leprosy relapse from a tertiary government hospital in Metro Manila: A 10-year retrospective study

Nazal MEBH, Sayo-Aguiling KJ, Abad-Venida ML. Lepra. Leprosy Review. 2025; 96 (4) : 1-12.
Download PDF
Publication

Paucibacillary leprosy in a 6-month-old infant in an endemic area of Malaysia: a clinical case report

Benedict S, Mun WC, Mohd. Saidi NS, et al. Lepra. Leprosy Review. 2025; 96 (4) : 1-4.
Download PDF
Publication

Molecular detection of mutations in the gyrA gene associated with fluoroquinolone resistance in Mycobacterium leprae strains from leprosy patients in Adzopé, Côte d’Ivoire

Roger DB, Christiane AA, Jean-Luc TG, et al. Lepra. Leprosy Review. 2025; 96 (4) : 1-8.
Download PDF
Publication

Dapsone‐Induced Hypersensitivity Pneumonitis in Borderline Tuberculoid Leprosy

Choudhary SR, Bhatnagar A, Chalise S, et al. Wiley. International Journal of Dermatology. 2025;
Publication

Dapsone Hypersensitivity Syndrome with multisystem involvement in a case of Borderline Tuberculoid Hansen’s disease

Jindal A, Alam R, Goel S, et al. Lepra. Leprosy Review. 2025; 96 (4) : 1-7.
Download PDF
Publication

Leprosy in the 21st century: a comprehensive review of immunological mechanisms, diagnosis, and treatment

Froes Junior LAR, Sotto MN, Trindade MAB. FapUNIFESP (SciELO). Revista do Instituto de Medicina Tropical de São Paulo. 2025;
Download PDF
Publication

Comparison of MRM-C and WHO-MDT Regimens in Multibacillary Leprosy: A Retrospective Cohort Study

Rana N, Rehman BU, Talat H, et al. Saidu Medical College. Journal of Saidu Medical College. 2025; 15 (4) : 594-600.
Download PDF
Publication

Two Foes, One Host: The Poignant Coexistence of Hansen’s Disease and Hepatitis B

Saha D, Yadav L. GSC Online Press. Magna Scientia Advanced Research and Reviews. 2025; 15 (1) : 157-164.
Download PDF
Publication

Erythema Nodosum Leprosum in a Treatment-Naïve Patient: Clinical Clues Not to Miss in Primary Care

Samsudin S, Hamzah F. Asian Journal of Medicine and Health Sciences. 2025;
Download PDF
Publication

Dapsone Hypersensitivity Syndrome in Leprosy.

Sagar H. The American journal of tropical medicine and hygiene. 2025;
Download PDF

Pagination

  • Page 1
  • Next page ››
Subscribe to Multi-drug therapy (MDT)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD